Randox Food Diagnostics will be holding roadshows as part of its major series targeting the honey market for antibiotic screening.
The move marks the start of a new strategic approach by the UK-based firm to increase face-to-face engagement with the market.
Business development manager Aaron Tohill explained: “As the reputation of our patented multiplex drug residue screening system, BioChip Array Technology, continues to grow within the honey market, we’ve found the interest at Conferences and Exhibitions a revelation. So we decided, rather than wait for events coming around, we would proactively create opportunities for the industry to experience BioChip Array for themselves.”
The firm is initially targeting two strategic regions. Tohill added: “Building on the success of Apimondia in Ukraine we recognise the strength of the eastern European region. The other key region is Central America, where we are planning a tour for Mexico in March, before arriving in Cuba in July. However we want to roll-out the demonstrations wherever demand arises so if producers in neighbouring countries or other regions are interested we are keen to hear from them.”
BioChip Array Technology can detect multiple antibiotics from a single honey sample, adding potential for savings via time and cost.
Honey is a direct application with easy sample preparation, speed and reliability of results (false positives < 5%). To book a place contact info@randoxfooddiagnostics.com
